Nicholas Kartsonis Selected Research

Nicholas Kartsonis Research Topics

6	Invasive Candidiasis 01/2020 - 12/2002
5	Infections 01/2020 - 10/2002
5	Candidiasis (Moniliasis) 01/2020 - 10/2002
4	Mycoses (Diseases, Fungus) 03/2016 - 01/2006
4	Neutropenia 03/2016 - 12/2002
3	Aspergillosis 12/2006 - 07/2005
1	Reinfection 01/2017
1	Clostridium Infections 01/2017
1	Body Weight (Weight, Body) 01/2017
1	Graft vs Host Disease (Graft-Versus-Host Disease) 03/2016
1	Neoplasms (Cancer) 03/2016
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2014
1	Nausea 10/2014
1	Invasive Fungal Infections 10/2014
1	Vomiting 10/2014
1	Mucositis 10/2014
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 10/2014
1	Wound Infection (Wound Infections) 09/2013
1	Bacteremia 09/2013
1	Cross Infection (Nosocomial Infection) 09/2013
1	Osteomyelitis 08/2007
1	Arthritis (Polyarthritis) 08/2007
1	Infectious Arthritis (Septic Arthritis) 08/2007
1	Endocarditis 08/2007
1	Peritonitis 08/2007
1	Abdominal Abscess 08/2007
1	Pulmonary Aspergillosis 12/2006
1	Candidemia 12/2002
1	Esophagitis 10/2002

9	Caspofungin (Cancidas)FDA Link 01/2020 - 10/2002
4	posaconazole FDA Link 03/2016 - 07/2014
3	TabletsIBA 03/2016 - 10/2014
2	deoxycholate drug combination amphotericin BIBA 01/2020 - 12/2002
2	EchinocandinsIBA 12/2006 - 10/2002
2	Amphotericin B (Amphotericin)FDA LinkGeneric 12/2002 - 10/2002
1	actoxumabIBA 01/2017
1	bezlotoxumabIBA 01/2017
1	SuspensionsIBA 03/2016
1	CyclodextrinsIBA 07/2014
1	SolutionsIBA 07/2014
1	VaccinesIBA 09/2013
1	TriazolesIBA 12/2006
1	Indicators and Reagents (Reagents)IBA 01/2006
1	EnzymesIBA 07/2005
1	galactomannanIBA 07/2005
1	ImmunosorbentsIBA 07/2005
1	Pharmaceutical PreparationsIBA 10/2002
1	AzolesIBA 10/2002
1	Fluconazole (Zonal)FDA LinkGeneric 10/2002